EHRS-FM IG

ISO/HL7 10781 - Electronic Health Record System Functional Model, Release 2.1
0.14.0 - CI Build

ISO/HL7 10781 - Electronic Health Record System Functional Model, Release 2.1 - Local Development build (v0.14.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

Requirements: CP.4.5 Manage Orders for Blood Products and Other Biologics (Function)

Active as of 2024-06-01
Statement N:

Communicate with appropriate sources or registries to manage orders for blood products or other biologics.

 Description I:

Interact with a blood bank system or other source to support orders for blood products or other biologics including discontinuance orders. Use of such products in the provision of care is captured. Blood bank or other functionality that may come under jurisdictional law or other regulation (e.g., by the FDA in the United States) is not required; functional communication with such a system is required.

 Criteria N:
CP.4.5#01 SHALL

The system SHALL provide the ability to manage orders for blood products and biological products.
CP.4.5#02 SHALL

The system SHALL provide the ability to manage the status (e.g., requisitioned, completed, in process) of blood product, and/or biological product orders.
CP.4.5#03 SHALL

The system SHALL provide the ability to manage storage request orders for blood products, and/or biological products.
CP.4.5#04 SHALL

The system SHALL provide the ability to manage the status of storage request orders (e.g., requisitioned, completed, in process) for blood products, and/or biological products.
CP.4.5#05 SHALL

The system SHALL conform to function [[CPS.9.2]] (Support for Inter-Provider Communication) to provide the ability to exchange blood product, and/or biological products between members of the care team.
CP.4.5#06 SHALL

The system SHALL provide the ability to manage the use of blood products and other biologics in the provision of care.
CP.4.5#07 SHOULD

The system SHOULD provide the ability to manage information associated with the collection and administration of non-blood biologics (e.g., breast milk products), including donor and recipient, and/or patient-identifying data, aliquot-identifying data, amount, route (e.g., oral versus tube), expiration date and time of administration.